These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

745 related items for PubMed ID: 17785436

  • 1. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA, Tapia JC, Rodriguez DA, Lladser A, Arredondo C, Leyton L, Quest AF.
    Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
    [Abstract] [Full Text] [Related]

  • 2. Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin.
    Torres VA, Tapia JC, Rodríguez DA, Párraga M, Lisboa P, Montoya M, Leyton L, Quest AF.
    J Cell Sci; 2006 May 01; 119(Pt 9):1812-23. PubMed ID: 16608879
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
    Wang Q, Sun Z, Yang HS.
    Oncogene; 2008 Mar 06; 27(11):1527-35. PubMed ID: 17828298
    [Abstract] [Full Text] [Related]

  • 4. Caveolin-1-mediated suppression of cyclooxygenase-2 via a beta-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression.
    Rodriguez DA, Tapia JC, Fernandez JG, Torres VA, Muñoz N, Galleguillos D, Leyton L, Quest AF.
    Mol Biol Cell; 2009 Apr 06; 20(8):2297-310. PubMed ID: 19244345
    [Abstract] [Full Text] [Related]

  • 5. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE, Wang MX, Li RQ.
    Cancer Invest; 2009 Jul 06; 27(6):604-12. PubMed ID: 19440933
    [Abstract] [Full Text] [Related]

  • 6. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts.
    Kuphal F, Behrens J.
    Exp Cell Res; 2006 Feb 15; 312(4):457-67. PubMed ID: 16368435
    [Abstract] [Full Text] [Related]

  • 7. Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2.
    Calviello G, Resci F, Serini S, Piccioni E, Toesca A, Boninsegna A, Monego G, Ranelletti FO, Palozza P.
    Carcinogenesis; 2007 Jun 15; 28(6):1202-9. PubMed ID: 17183061
    [Abstract] [Full Text] [Related]

  • 8. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
    Sakoguchi-Okada N, Takahashi-Yanaga F, Fukada K, Shiraishi F, Taba Y, Miwa Y, Morimoto S, Iida M, Sasaguri T.
    Biochem Pharmacol; 2007 May 01; 73(9):1318-29. PubMed ID: 17270149
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
    Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A, Rimm DL, Costa J, Fearon ER.
    Cell Growth Differ; 1999 Jun 01; 10(6):369-76. PubMed ID: 10392898
    [Abstract] [Full Text] [Related]

  • 11. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression.
    Quasnichka H, Slater SC, Beeching CA, Boehm M, Sala-Newby GB, George SJ.
    Circ Res; 2006 Dec 08; 99(12):1329-37. PubMed ID: 17122440
    [Abstract] [Full Text] [Related]

  • 12. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
    Eger A, Stockinger A, Park J, Langkopf E, Mikula M, Gotzmann J, Mikulits W, Beug H, Foisner R.
    Oncogene; 2004 Apr 08; 23(15):2672-2680. PubMed ID: 14755243
    [Abstract] [Full Text] [Related]

  • 13. Vitamin D receptor modulates the neoplastic phenotype through antagonistic growth regulatory signals.
    Xu H, McCann M, Zhang Z, Posner GH, Bingham V, El-Tanani M, Campbell FC.
    Mol Carcinog; 2009 Aug 08; 48(8):758-72. PubMed ID: 19184984
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Down-regulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiation.
    Mariadason JM, Bordonaro M, Aslam F, Shi L, Kuraguchi M, Velcich A, Augenlicht LH.
    Cancer Res; 2001 Apr 15; 61(8):3465-71. PubMed ID: 11309309
    [Abstract] [Full Text] [Related]

  • 16. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.
    Faux MC, Ross JL, Meeker C, Johns T, Ji H, Simpson RJ, Layton MJ, Burgess AW.
    J Cell Sci; 2004 Jan 26; 117(Pt 3):427-39. PubMed ID: 14679305
    [Abstract] [Full Text] [Related]

  • 17. beta-Catenin regulates P-cadherin expression in mammary basal epithelial cells.
    Faraldo MM, Teulière J, Deugnier MA, Birchmeier W, Huelsken J, Thiery JP, Cano A, Glukhova MA.
    FEBS Lett; 2007 Mar 06; 581(5):831-6. PubMed ID: 17292359
    [Abstract] [Full Text] [Related]

  • 18. Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells.
    de la Taille A, Rubin MA, Chen MW, Vacherot F, de Medina SG, Burchardt M, Buttyan R, Chopin D.
    Clin Cancer Res; 2003 May 06; 9(5):1801-7. PubMed ID: 12738737
    [Abstract] [Full Text] [Related]

  • 19. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines.
    Yang SZ, Kohno N, Yokoyama A, Kondo K, Hamada H, Hiwada K.
    Int J Oncol; 2001 Mar 06; 18(3):541-8. PubMed ID: 11179484
    [Abstract] [Full Text] [Related]

  • 20. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.
    Hsu YM, Chen YF, Chou CY, Tang MJ, Chen JH, Wilkins RJ, Ellory JC, Shen MR.
    Cancer Res; 2007 Nov 15; 67(22):11064-73. PubMed ID: 18006853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.